Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$215,193.00
Jul 21, 2022
Not-for-profit organization or charity
Selection and validation of the targeted population and clinical biomarkers to support Phase I/II trials and long-term monitoring of patients treated with the LPLD gene therapy
992766
The current project aims at obtaining relevant data to select the targeted population and clinical biomarkers for the long-term monitoring of efficacy of LPLD gene therapy to support Phase I/II clinical trial design to be proposed to Health Canada at a pre-CTA meeting Definition and validation of the study population and of the main inclusion and exclusion criteria will be performed using data obtained from discussions with Canadian/international experts and from the documentation of the natural history of LPL deficiency, including epigenetic, gene expression and sequencing analyses. The natural history of LPL deficiency, including a panel of critical biomarkers, will become a ‘baseline’ against which to benchmark long-term efficacy of LPLD gene therapy. The analysis and selection of clinical biomarkers will leverage the ongoing research program on the natural history of severe hypertriglyceridemia (SMASH: Systems and Molecular Approaches of Severe Hyperlipidemias) (Table 1). In parallel, the same panel of biomarkers will be monitored in preclinical long-term safety and efficacy study of the lead LPLD gene therapy construct in LPL-/- transgenic mice conducted by UBC. This will provide pre-clinical baseline of potential effect of gene therapy treatment on selected biomarkers representative of the ‘natural’ history of disease in humans. ( Figure 1). Studies above will allow to identify safety and efficacy assessment criteria that will be used in the clinical trial, including the definition of the primary and secondary objectives, as well as to identify all potential concurrent and companion treatments. Finally, socioeconomic study of chylomicronemia and pharmacoeconomic analyses will be performed to position this new gene therapy in relation to the competitive environment and the burden of LPL deficiency
$6,316.00
Jun 1, 2020
Not-for-profit organization or charity
Through the application of national and local priorities, the CSJ program seeks to provide youth, particularly those who face barriers to employment with access to work opportunities. Funded employers must demonstrate that they are providing quality work experiences for youth that provide opportunities to develop and improve their skills.
$3,984.00
Jun 13, 2019
Through the application of national and local priorities, the CSJ program seeks to provide youth who face barriers to employment with access to work opportunities. Funded employers must demonstrate that they are providing quality work experiences for youth that provide opportunities to develop and improve their skills. The CSJ program is delivered by the Department of ESD.
$2,882.00
May 14, 2018
EEC 22 - Ecogene 21
15448327
N/A